How can we evaluate the potential of innovative vaccine products and technologies in resource constrained settings? A total systems effectiveness (TSE) approach to decision-making

Innovations in vaccine product attributes could play an important role in addressing coverage and equity (C&E) gaps, but there is currently a poor understanding of the full system impact and trade-offs associated with investing in such technologies, both from the perspective of national immunisa...

Descripción completa

Detalles Bibliográficos
Autores principales: Botwright, Siobhan, Kahn, Anna-Lea, Hutubessy, Raymond, Lydon, Patrick, Biey, Joseph, Karim Sidibe, Abdoul, Diarra, Ibrahima, Nadjib, Mardiati, Suwantika, Auliya A., Setiawan, Ery, Archer, Rachel, Kristensen, Debra, Menozzi-Arnaud, Marion, Mpia Bwaka, Ado, Mwenda, Jason M., Giersing, Birgitte K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Regular paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7644745/
https://www.ncbi.nlm.nih.gov/pubmed/33196036
http://dx.doi.org/10.1016/j.jvacx.2020.100078

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7644745/
https://www.ncbi.nlm.nih.gov/pubmed/33196036
http://dx.doi.org/10.1016/j.jvacx.2020.100078

Ejemplares similares